China Ramps Up Diagnostics Efforts To Deal With Diabetes Surge; Mandates Screening For At-risk Populations
This article was originally published in PharmAsia News
Executive Summary
China will enact regulations to mandate regular screening for diabetes among high-risk populations, which could spur a surge in demand for diabetes treatments and diagnostic devices that dwarfs that of the United States.